Document 0567 DOCN M9590567 TI Cryptic dysfunction of cellular immunity in asymptomatic human immunodeficiency virus (HIV) carriers and its actualization by an environmental immunosuppressive factor. DT 9509 AU Sugiura M; Imai S; Sakurada K; Miyazaki T; Osato T; Department of Virology, Hokkaido University School of Medicine,; Sapporo, Japan. SO In Vivo. 1994 Nov-Dec;8(6):1019-22. Unique Identifier : AIDSLINE MED/95290636 AB Peripheral blood lymphocytes from 4 asymptomatic HIV-1 carriers with normally retained EBV-specific cytotoxic T-cell activity were exposed to EBV and incubated with 0.2 ng/ml 4-deoxyphorbol ester, an immunosuppressive substance derived from an African plant Euphorbia tirucalli. The regression of EBV-induced B-cell transformation by EBV-specific cytotoxic T-cells was significantly impaired in the presence of a small amount of 4-deoxyphorbol ester, but not so in 5 HIV-1-seronegative healthy counterparts. When the EBV-specific cytotoxic T-cells from the asymptomatic carriers were exposed to 0.2ng/ml 4-deoxyphorbol ester and incubated with 51Cr-labeled autologous EBV-transformed B lymphocytes, the released radioactivity was significantly smaller than that of the healthy counterparts. The results suggest that the cellular immunity of the asymptomatic HIV-1 carriers is cryptically impaired, and the cryptic immunological dysfunction is actualized by exposure to a small amount of the immunosuppressive substance, a dose which does not affect the immunity of uninfected healthy individuals. DE Adolescence Adult Carrier State Cell Line Female Herpesvirus 4, Human/*IMMUNOLOGY Human HIV Seropositivity/*IMMUNOLOGY *HIV-1 Immunity, Cellular/*DRUG EFFECTS Male Middle Age Phorbol Esters/PHARMACOLOGY Support, Non-U.S. Gov't T-Lymphocytes, Cytotoxic/CYTOLOGY/*DRUG EFFECTS/IMMUNOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).